Alice Zhang appeared on Forbes' 2017 list of the 30 Under 30 in Science.Jamel Toppin for Forbes Alice Zhang, 29, was a graduate student at UCLA when she decided there was a tremendous opportunity to speed up the process of drug development. "I started becoming frustrated with how drug discovery was done. I viewed it as a guessing game and largely focused on single targets. In our lab, we were finding that literally hundreds of targets were causing disease. We could start taking the guesswork out of drug discovery." This morning, Zhang's company, Verge Genomics, is announcing that it is securing $32 million in funding led by DFJ, formerly known as Draper Fisher Jurvetson.